How NAD+ Injections, Patches, and IVs Actually Perform at 45

Your energy crashed somewhere around 42, your skin stopped bouncing back, and now every wellness account in your feed is selling you a $1,000 IV drip as the fix. This article gives you the actual pharmacokinetic data, real costs, and honest evidence grades for every NAD+ delivery method so you can spend on what works and skip what doesn't.

Here's the uncomfortable truth the IV lounges won't lead with: no NAD+ delivery method (IV, injection, or patch) has a single published randomized controlled trial proving clinical efficacy for any outcome. The strongest human evidence actually favors oral precursors, specifically nicotinamide riboside (NR), which raised blood NAD+ approximately 161% in 8 days in a head-to-head crossover trial. And oral NR costs a fraction of what clinics charge for infusions.

That doesn't mean IVs and injections are worthless. It means you deserve the real breakdown before you hand over your credit card.

Key Takeaways:

• NAD+ levels decline roughly 50% between ages 40 and 60, making restoration a legitimate optimization target, not a marketing invention.
• IV NAD+ infusions cost $250 to $1,000+ per session (2024/2025 pricing), yet the only published pharmacokinetic study found that most infused NAD+ is broken down or excreted, not absorbed into cells.
• Oral NR at 300 to 1,000 mg/day raises blood NAD+ by 51% to 142% within two weeks, with dose-dependent increases confirmed in multiple human trials, at $40 to $120/month.
• NAD+ patches have zero peer-reviewed human trials, and bioavailability through intact skin remains completely unestablished.
• Subcutaneous NAD+ injections deliver roughly 20 mg per dose, far below IV doses of 500 to 1,000 mg, with no controlled efficacy data published.
• The best-evidence-per-dollar route for most women is oral NR at 300 to 1,000 mg/day, with IV infusions reserved for those who want the experiential protocol and have the budget to match.

---

Why Your NAD+ Levels Drop After 40 and What That Actually Means

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme in every cell of your body. It's required for energy production, DNA repair, and the activity of sirtuins, the proteins that regulate cellular aging. Without enough of it, mitochondria underperform, repair processes slow, and the downstream effects show up as fatigue, slower recovery, thinning skin, and metabolic sluggishness.

The decline is measurable and well-documented. NAD+ levels drop steadily after your 30s, with estimates suggesting a roughly 50% reduction between ages 40 and 60. This isn't fringe science. It's basic cellular biology, and it's one of the reasons your body at 45 doesn't recover, repair, or produce energy the way it did at 28.

The real question isn't whether NAD+ matters. It does. The question is whether the delivery method you're being sold can actually get NAD+ where it needs to go: inside your cells. NAD+ is a large molecule. It doesn't cross cell membranes easily. When you pour it directly into your bloodstream via IV, a significant portion gets broken down extracellularly (outside the cell) before it ever reaches the interior of a cell. When you take a precursor like NR orally, your body converts it through established metabolic pathways that cells already use.

This distinction, the difference between raising plasma NAD+ (blood levels) and raising intracellular NAD+ (the number that actually matters), is the thing most clinic marketing conveniently skips. Keep it in mind as we go through every route.

---

NAD+ IVs, Injections, Patches, and Oral Precursors Compared

Before we get into the evidence deep-dive, here's the scannable comparison. Bookmark this.

A few things jump out immediately. The most expensive option (IV) has the thinnest efficacy evidence. The cheapest option (oral NR) has the most published human data. And the trendiest option (patches) has literally nothing behind it.

Let's get into why.

---

What the Clinical Evidence Actually Shows for Each Route

IV NAD+: One Pilot Study, No Efficacy Trial

The Grant et al. 2019 study is the only published human pharmacokinetic study of IV NAD+ infusion. Eleven healthy volunteers received 750 mg of NAD+ over six hours. The central finding: infused NAD+ did not produce a clean, sustained rise in plasma NAD+. Instead, it was substantially metabolized in circulation, with urinary NAD+ metabolite levels jumping 538% during the infusion. Translation: a huge portion of what they pumped in got broken down or peed out.

Liver and kidney function remained stable. No infusion-related adverse events were reported. That's reassuring for safety, but it tells you nothing about whether the treatment actually does what clinics claim it does.

At the time of writing (mid-2025), no published randomized controlled trial has reported a clinical efficacy endpoint for IV NAD+ in any indication. Not energy. Not cognition. Not skin quality. Not longevity markers. The clinical use that exists is built on case series, clinic-level outcome reports, and extrapolation from oral precursor data.

Evidence grade: D (single small PK study, zero efficacy RCTs). Women who report feeling amazing after an IV session are reporting something real to them, but placebo effects are potent, hydration alone improves how you feel, and a 2 to 6 hour commitment in a calm clinic environment is its own kind of reset. None of that requires $750 worth of NAD+.

Subcutaneous Injections: Low Dose, No Data

Subcutaneous NAD+ injections typically deliver about 20 mg per dose. Compare that to IV doses of 500 to 1,000 mg. The math alone should give you pause. Even if we grant the estimated 70 to 80% bioavailability into the bloodstream, you're working with a fraction of the dose, subject to the same extracellular breakdown, and there are no controlled efficacy studies published for this route.

Like most research peptides, injectable NAD+ isn't FDA-approved for anti-aging or optimization purposes, which is exactly why the interesting real-world evidence lives in what women are actually reporting. And women on these protocols do consistently report improved energy and mental clarity, particularly when injections are part of a broader peptide stack. But the published data to support NAD+ injections specifically, independent of other interventions, simply doesn't exist yet.

Evidence grade: E (no published controlled data at subcutaneous doses).

Transdermal Patches: Marketing Without a Mechanism

No peer-reviewed human clinical trial has evaluated the efficacy of NAD+ patches. Bioavailability of NAD+ through intact skin remains completely unestablished. NAD+ is a large, hydrophilic (water-loving) molecule, and transdermal delivery of large hydrophilic molecules is one of the hardest problems in drug delivery. The skin is specifically designed to keep molecules like this out.

Some patch companies cite "iontophoresis" or proprietary delivery technology, but none have published human absorption data in a peer-reviewed journal. Until someone does, this is a product category built on claims with no supporting evidence.

Evidence grade: E (zero human trials, no established delivery mechanism).

Oral NR: The Actual Data Leader

This is where the evidence lives.

A 2026 crossover trial from Haukeland University Hospital (Berven et al.) gave healthy participants NR and NMN at matched gram doses. NR raised whole-blood NAD+ from approximately 27 μM to 70.5 μM by day 8, a 161% increase from baseline. NMN raised it from approximately 32 μM to 53.7 μM, a 69% increase. NR produced roughly 2.3 times the NAD+ increase of NMN at the same dose.

A separate study from Nestlé Research (Christen/Cuenoud et al., 2025) confirmed that both NR and NMN approximately double circulating NAD+ levels after 14 days of supplementation, while nicotinamide (plain vitamin B3) provided only a transient, acute spike with no sustained elevation.

Earlier dose-response work showed NAD+ increases of approximately 22%, 51%, and 142% at NR doses of 100, 300, and 1,000 mg respectively within two weeks. A single 1,000 mg dose of NR raised blood NAD+ up to 2.7-fold in one individual.

Evidence grade: B (multiple human PK and crossover trials, dose-response confirmed, but still limited clinical-outcome RCTs connecting blood NAD+ increases to specific health endpoints).

Oral NMN: Solid, But Second Place in Head-to-Head

NMN is a legitimate precursor that does raise NAD+ in humans. The Christen 2025 data shows it roughly doubles blood NAD+ at 14 days, comparable to NR. But in the only direct head-to-head comparison (Berven 2026), NR outperformed it by a factor of 2.3x at the same gram dose. NMN's slightly larger molecular weight means you need more milligrams to deliver the same molar amount of precursor, and even after correcting for that, NR still came out ahead.

Evidence grade: B- (growing human data, but fewer head-to-head comparisons and slightly weaker performance against NR in the best available crossover trial).

---

What NAD+ Therapy Costs and Where the Money Actually Goes

Let's do the math that clinics hope you won't. Use our dose and cost calculators to run the numbers for your specific protocol.

A popular IV loading protocol looks like this: 4 infusions in the first 2 weeks at $500 to $750 each ($2,000 to $3,000 just to start), then monthly maintenance at $500 to $1,000. That's $8,000 to $15,000 in year one. Some premium clinics in LA and Miami charge $1,500 per session, pushing annual costs above $20,000.

Oral NR at 1,000 mg/day from a reputable brand runs about $80 to $120/month, or roughly $960 to $1,440/year. For context, that's less than a single IV session at most clinics.

The price difference would be justified if IV NAD+ had dramatically better outcomes. It doesn't. It has dramatically better marketing.

Where your IV money actually goes: clinic overhead (rent, staff, medical director salary, liability insurance), compounding pharmacy markup on the NAD+ solution, and the 2 to 6 hours of nursing time to monitor your infusion. The NAD+ itself is a small fraction of the total bill. You're paying for the experience and the setting, which is fine if you know that's what you're buying.

---

Side Effects and Safety at Every Dose

IV Infusions

The most commonly reported side effects during IV NAD+ infusions are flushing, nausea, chest tightness, and a feeling of pressure or warmth. These are rate-dependent, meaning they get worse when the drip runs faster. Most clinics manage this by slowing the infusion rate, which is why sessions often stretch to 4 to 6 hours.

In the Grant 2019 pilot study, no infusion-related adverse events were reported at 750 mg over six hours, and liver and kidney function tests remained stable. A case report involving Parkinson's disease patients using IV NAD+ noted symptom improvement with no major side effects. No serious adverse events have appeared in published human trials at therapeutic doses.

The real safety concern with IVs isn't the NAD+ itself. It's the clinical setting. An IV is a needle in your vein for hours. Infection risk, infiltration (the IV slipping out of the vein), and air embolism are all possible if the clinic cuts corners on sterile technique or monitoring. This is why provider selection matters enormously (more on that below).

Subcutaneous Injections

Injection-site reactions (redness, swelling, mild pain) are the primary reported issue. At the low doses typically used (around 20 mg), systemic side effects appear uncommon in anecdotal reports, but again, no controlled safety data exists for this specific route and dose.

Transdermal Patches

No safety data, because no trials exist. The absence of reported problems is not the same as established safety. It just means nobody has studied it.

Oral Precursors (NR and NMN)

A 2023 systematic review of oral NAD+ supplements found no severe safety concerns. Reported side effects were mild: headache, nausea, fatigue, and occasional sleep disturbance. These tended to occur at higher doses and often resolved within the first week or two.

NR has the longest safety track record in published human trials, with doses up to 1,000 mg/day studied and shown to raise NAD+ levels dose-dependently without serious adverse events. NMN safety data is growing but thinner.

Genuine Contraindications Worth Knowing

If you're on immunosuppressants, chemotherapy, or have an active cancer diagnosis, NAD+ supplementation (any route) needs a conversation with your oncologist. Some research suggests NAD+ could theoretically support the metabolism of cancer cells alongside healthy ones. This isn't a reason to panic, but it is a reason to disclose and discuss.

Pregnancy and breastfeeding: insufficient data for any route. Don't wing it.

If you're taking blood thinners or have a bleeding disorder, IV access carries additional risk. Your provider should be asking about this before scheduling.

---

How to Find a Legitimate NAD+ Provider

If you decide IV or injectable NAD+ is your route, provider quality is the single biggest variable in your experience and safety.

What a good clinic looks like:

• A named medical director (MD or DO) who is on-site or available during infusions, not just a signature on a wall
• NAD+ sourced from a licensed 503A or 503B compounding pharmacy (ask for the pharmacy name and verify it)
• Pre-treatment intake that includes a health history, current medications, and baseline labs (at minimum: CBC, CMP, liver function). If they don't ask, leave.
• A nurse or paramedic monitoring you during the infusion, not just checking in every 45 minutes
• Clear documentation of what's in your IV bag, the dose, and the infusion rate
• Post-treatment follow-up protocol, ideally including repeat NAD+ testing at 4 to 8 weeks

Red flags that should send you elsewhere:

• No intake labs or health questionnaire
• Claims that NAD+ IV "cures" anything (addiction, Alzheimer's, aging)
• Pricing that seems too low ($150 for a 500 mg infusion means someone is cutting corners on sourcing, staffing, or both)
• Inability to tell you which compounding pharmacy supplies their NAD+
• Pressure to buy multi-session packages before your first infusion
• No medical professional present during the infusion

For oral precursors: You don't need a prescription for NR or NMN supplements, but a provider who understands NAD+ biology can help you pick the right dose, interpret baseline and follow-up testing, and integrate it with your broader protocol. Telehealth longevity and anti-aging practices increasingly offer this. Look for providers who order intracellular NAD+ testing (not just blood levels) and who can explain the difference.

---

Your NAD+ Route Map Based on Budget and Evidence Tolerance

You now have the data. Here's how to use it.

If you want the strongest evidence per dollar spent: Oral NR at 300 to 1,000 mg/day is the move. Start at 300 mg for 2 weeks, assess tolerance, then titrate up if you want more. Budget: $40 to $120/month. Get baseline intracellular NAD+ testing before you start and retest at 8 to 12 weeks. This is the route with multiple human trials behind it, clear dose-response data, and the lowest risk profile.

If you want the experiential protocol and have the budget: IV NAD+ infusions with before-and-after intracellular NAD+ testing. Go in with open eyes. You're paying for the experience and the possibility that direct infusion does something oral can't, but the published data doesn't confirm that yet. Budget: $3,000 to $15,000+ per year depending on frequency and clinic. Combine with daily oral NR for sustained baseline elevation between sessions.

If you're considering subcutaneous injections: This route makes more sense as part of a broader peptide protocol managed by a peptide-literate provider than as a standalone NAD+ strategy. The dose per injection (~20 mg) is low enough that you'd need to pair it with oral precursors anyway. Women who run injectable NAD+ alongside compounds like GHK-Cu or BPC-157 often report that the combination feels synergistic, though this is experiential data, not trial-backed. Find a provider who can build and monitor the full stack.

If you're considering patches: The honest answer is there's nothing to support this route yet. Not thin evidence. Not early evidence. Zero evidence. Save your money until someone publishes actual human absorption data.

The bottom line math: A woman spending $750/month on twice-monthly IV NAD+ infusions could instead spend $100/month on high-quality NR, get baseline and follow-up NAD+ testing ($150 to $300 per test), and still save over $7,000 a year, while using the route with better published data. That leftover budget buys a lot of GHK-Cu.

Not sure which NAD+ route fits your goals and budget? Build your Get Hot plan for a personalized protocol recommendation.

Ready to find a provider who actually knows what they're doing with NAD+? [Compare NAD+ and peptide providers here.]

---

FAQ

Does NAD+ IV therapy actually raise intracellular NAD+ levels or just blood levels? The Grant 2019 pharmacokinetic study showed that IV NAD+ is substantially metabolized in the bloodstream before reaching cells, with urinary metabolite excretion jumping 538% during infusion. Whether meaningful amounts reach intracellular compartments remains unproven. Most clinics measure only blood levels, which isn't the same thing. Ask for intracellular NAD+ testing (offered by specialty labs) if you want the number that actually matters.

How long do the effects of a single NAD+ IV infusion last? No published study has established a duration-of-effect curve for IV NAD+. Women who get infusions typically report feeling the subjective effects (energy, mental clarity) for 1 to 3 weeks, which is why monthly maintenance sessions are common. Without controlled data, it's impossible to separate the NAD+ effect from placebo, hydration, and the rest-and-recovery benefit of spending 4 hours in a quiet room.

Are NAD+ patches backed by any clinical research? No. Zero peer-reviewed human clinical trials have evaluated NAD+ patches. Bioavailability of NAD+ through intact skin is unestablished. NAD+ is a large, hydrophilic molecule that skin is specifically designed to block. Until published absorption data exists, patches are a marketing product, not an evidence-based delivery method.

Is oral NR better than NMN for raising NAD+ levels? In the best available head-to-head crossover trial (Berven et al., 2026), NR raised blood NAD+ approximately 2.3 times more than NMN at the same gram dose over 8 days. A separate 14-day trial (Christen/Cuenoud 2025) found both roughly doubled blood NAD+. The weight of current evidence favors NR for raw NAD+ elevation, though NMN remains a legitimate option, especially for those who tolerate it better.

How much does a full NAD+ IV protocol cost per year? A typical loading phase (4 sessions in 2 weeks) runs $2,000 to $4,000. Monthly maintenance at $500 to $1,000 per session adds $6,000 to $12,000. Total first-year cost: $8,000 to $16,000 at mid-range clinics. Premium clinics in major metros can push this above $20,000. Compare that to oral NR at $480 to $1,440/year.

What side effects should I expect from NAD+ IV therapy? Flushing, nausea, chest tightness, and a sensation of warmth or pressure are common during infusion, especially at faster drip rates. These are typically managed by slowing the infusion. No serious adverse events have been reported in published human trials at therapeutic doses. Liver and kidney function remained stable in the Grant 2019 pilot study.

Can I test my NAD+ levels before and after treatment? Yes. Intracellular NAD+ testing is available through specialty labs (Jinfiniti is the most widely used as of 2025). A single test costs approximately $150 to $300. Testing before starting any protocol and again at 8 to 12 weeks gives you objective data on whether your chosen route is working. This is the single most useful thing you can do regardless of which delivery method you pick.

How do I know if an NAD+ clinic is legitimate? Look for a named medical director (MD/DO), NAD+ sourced from a licensed compounding pharmacy (ask for the name), pre-treatment labs and health history intake, continuous monitoring during infusions, and a follow-up testing protocol. If they can't tell you where their NAD+ comes from or don't require any intake assessment, find a different clinic.

Do I need a prescription for NAD+ injections? Yes. Injectable NAD+ requires a prescription and is typically sourced from a compounding pharmacy. You'll need a provider (MD, DO, NP, or PA in most states) to prescribe it. Oral NR and NMN supplements do not require a prescription and are available over the counter.

What dose of oral NR actually moves the needle on NAD+ levels? Published human data shows dose-dependent NAD+ increases: approximately 22% at 100 mg/day, 51% at 300 mg/day, and 142% at 1,000 mg/day within two weeks. The Berven 2026 crossover trial used 1,000 mg/day and saw a 161% increase by day 8. For most women, 300 to 1,000 mg/day is the effective range, with 300 mg as a reasonable starting point and 1,000 mg as the well-studied upper dose.